- Home
- KRNY vs AQST Comparison
KRNY vs AQST Comparison
Compare KRNY & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRNY
- AQST
- Stock Information
- Founded
- KRNY 1884
- AQST 2004
- Country
- KRNY United States
- AQST United States
- Employees
- KRNY N/A
- AQST N/A
- Industry
- KRNY Savings Institutions
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- KRNY Finance
- AQST Health Care
- Exchange
- KRNY Nasdaq
- AQST Nasdaq
- Market Cap
- KRNY 436.9M
- AQST 502.6M
- IPO Year
- KRNY 2005
- AQST 2018
- Fundamental
- Price
- KRNY $8.19
- AQST $4.51
- Analyst Decision
- KRNY Hold
- AQST Strong Buy
- Analyst Count
- KRNY 1
- AQST 7
- Target Price
- KRNY $7.00
- AQST $9.43
- AVG Volume (30 Days)
- KRNY 364.8K
- AQST 1.7M
- Earning Date
- KRNY 10-24-2024
- AQST 11-04-2024
- Dividend Yield
- KRNY 5.37%
- AQST N/A
- EPS Growth
- KRNY N/A
- AQST N/A
- EPS
- KRNY N/A
- AQST N/A
- Revenue
- KRNY $128,413,999.00
- AQST $58,900,000.00
- Revenue This Year
- KRNY N/A
- AQST $18.45
- Revenue Next Year
- KRNY $28.55
- AQST N/A
- P/E Ratio
- KRNY N/A
- AQST N/A
- Revenue Growth
- KRNY N/A
- AQST 22.56
- 52 Week Low
- KRNY $5.28
- AQST $1.84
- 52 Week High
- KRNY $9.46
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- KRNY 62.26
- AQST 40.86
- Support Level
- KRNY $7.95
- AQST $4.36
- Resistance Level
- KRNY $8.59
- AQST $4.88
- Average True Range (ATR)
- KRNY 0.29
- AQST 0.37
- MACD
- KRNY 0.00
- AQST -0.07
- Stochastic Oscillator
- KRNY 76.88
- AQST 12.20
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.